Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey).

Access Care Clinic Dedicated Migraine Nurse Practice Survey Triage Waiting lists

Journal

Neurology and therapy
ISSN: 2193-8253
Titre abrégé: Neurol Ther
Pays: New Zealand
ID NLM: 101637818

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 09 12 2019
pubmed: 9 8 2020
medline: 9 8 2020
entrez: 9 8 2020
Statut: ppublish

Résumé

The parent study was a survey in 28 headache centers (6 countries) which identified five potential root causes for long waiting lists that limit patient access to specialist care. Here we performed an extension of the parent study to increase the panel of centers contacted, the representativeness of the analysis, and the statistical validity of the results, and to explore the role of dedicated headache clinics, triage, and specialized nurses. We conducted a 19-question survey using a sample of 239 headache centers (16 countries). The five-area framework identified in the parent study was confirmed and further developed by describing treatment center archetypes according to their setting (general neurology versus dedicated clinic) and resources available within the center (number of healthcare professional [HCPs] full-time-equivalent positions). In total, 474 HCPs were interviewed across 16 countries. The proportion of patients with chronic migraine and episodic migraine varied across centers and countries. There was limited access to specialized centers in this enlarged sample; with global average waiting list of 3.7 months for the first visit and 2.5 months for the follow-up visit. Long waiting lists for headache patient care is a major issue in several countries, with the waiting lists for new patient visits extending up to 14 months. The presence of a dedicated nurse was correlated positively with the use of triage for prioritization of patient access (correlation coefficient: 0.85) and completing migraine diary (0.71). This study confirmed differences across treatment center archetypes in terms of patients, waiting lists, level of delegation to nurse, and patient education and compliance, and provides support for the potential benefit of dedicated clinical settings for headache patients. The survey highlighted the potential role of nurses in patient education and waiting list prioritization, consequently benefiting headache centers.

Identifiants

pubmed: 32767268
doi: 10.1007/s40120-020-00205-4
pii: 10.1007/s40120-020-00205-4
pmc: PMC7606425
doi:

Types de publication

Journal Article

Langues

eng

Pagination

551-565

Références

World Health Organization. Atlas of headache disorders and resources in the world. 2011. URL: https://www.who.int/mental_health/management/who_atlas_headache_disorders.pdf . Accessed Oct 1, 2019
Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14(1):1.
doi: 10.1186/1129-2377-14-1 pubmed: 23566305 pmcid: 23566305
Silberstein SD. Considerations for management of migraine symptoms in the primary care setting. Postgrad Med. 2016;128(5):523–37.
doi: 10.1080/00325481.2016.1175912 pubmed: 27078039
Steiner TJ, Antonaci F, Jensen R, Lainez MJ, Lanteri-Minet M, Valade D. European Headache Federation; Global Campaign against Headache. Recommendations for headache service organisation and delivery in Europe. J Headache Pain. 2011;12(4):419–26.
doi: 10.1007/s10194-011-0320-x pubmed: 21380555 pmcid: 21380555
Novartis Q3 and 9M 2019 Condensed Interim Financial Report—Supplementary Data. https://ml-eu.globenewswire.com/Resource/download/54b44cbc-188b-48a6-bf59-7a844c1bcd87/ . Accessed Nov 30, 2019.
Steiner TJ, Göbel H, Jensen R, Lampl C, Paemeleire K, Linde M, Braschinsky M, Mitsikostas D, Gil-Gouveia R, Katsarava Z. European Headache Federation and Lifting The Burden: the Global Campaign against Headache. Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence. Headache Pain. 2019;20(1):24.
doi: 10.1186/s10194-019-0970-7
Schramm S, Uluduz D, Gouveia RG, Jensen R, Siva A, Uygunoglu U, Gvantsa G, Mania M, Braschinsky M, Filatova E, Latysheva N, Osipova V, Skorobogatykh K, Azimova J, Straube A, Eren OE, Martelletti P, De Angelis V, Negro A, Linde M, Hagen K, Radojicic A, Zidverc-Trajkovic J, Podgorac A, Paemeleire K, De Pue A, Lampl C, Steiner TJ, Katsarava Z. Headache service quality: evaluation of quality indicators in 14 specialist-care centres. J Headache Pain. 2016;17(1):111.
doi: 10.1186/s10194-016-0707-9 pubmed: 27933580 pmcid: 5145818
Pellesi L, Benemei S, Favoni V, Lupi C, Mampreso E, Negro A, Paolucci M, Steiner TJ, Ulivi M, Cevoli S, Guerzoni S. Quality indicators in headache care: an implementation study in six Italian specialist-care centres. J Headache Pain. 2017;18(1):55.
doi: 10.1186/s10194-017-0762-x pubmed: 28477307 pmcid: 5419950
Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe—evidence from the Eurolight study. J Headache Pain. 2018;19(1):10.
doi: 10.1186/s10194-018-0839-1 pubmed: 29392600 pmcid: 5794675
Gaul C, Visscher CM, Bhola R, Sorbi MJ, Galli F, Rasmussen AV, et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain. 2011;12(5):511–9.
doi: 10.1007/s10194-011-0364-y pubmed: 21779789 pmcid: 3173636
Jensen RH, Rasmussen A. Multidisciplinary team approach to headache care. Clin Pract. 2012;9(2):181–8.
doi: 10.2217/cpr.11.136
Cady R, Farmer K, Beach ME, Tarrasch J. Nurse-based education: an office-based comparative model for education of migraine patients. Headache. 2008;48(4):564–9.
doi: 10.1111/j.1526-4610.2008.00911.x pubmed: 18377379
Kainth P, Murphy N, Rossi S, Talabardon JN, Pedrazzoli M, Mascagni L, et al. Management of migraine and the accessibility of specialist care—findings from a multi-national assessment of 28 healthcare networks. Eur Neurol Rev. 2018;13(2):103–10.
doi: 10.17925/ENR.2018.13.2.103
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. Cephalalgia 2018; 38:1–211.
Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, et al. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2016;56:821–34.
doi: 10.1111/head.12774 pubmed: 27143127 pmcid: 5084794
Canadian Medical Association 2018. Available from: https://www.cma.ca/sites/default/files/2019-01/neurology-e.pdf . Accessed Nov 6, 2019
Neurology 2016 Factsheet. https://hwd.health.gov.au/webapi/customer/documents/factsheets/2016/Neurology.pdf . Accessed Nov 6, 2019
https://www.pkegroup.it/html/blog/quanti-sono-i-neurologi-in-italia.asp . Accessed Nov 19, 2019
https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/Statistik2016/Stat16AbbTab.pdf . Accessed Nov 19, 2019
Colombo F. Health workforce policies: right jobs, right skills, in the right places: The 6th International Jerusalem Conference on Health Policy. 2016. Available at: www.oecd.org/health/health-systems/Health-workforce-policies-Colombo-May2016.pdf . Accessed Oct 1, 2019
Blumenfeld A, Tischio M. Centre of excellence for headache care: group model at Kaiser Permanente. Headache. 2003;43:431–40.
doi: 10.1046/j.1526-4610.2003.03087.x pubmed: 12752747
Veenstra P, Kollen BJ, de Jong G, Baarveld F, van den Berg JP. Nurses improve migraine management in primary care. Cephalalgia. 2016;36(8):772–8.
doi: 10.1177/0333102415612767 pubmed: 26487468

Auteurs

Siriporn Wongsiriroj (S)

Novartis (Thailand) Limited, Bangkok, Thailand. siriporn.wongsiriroj@novartis.com.

Elisabetta Grillo (E)

Novartis Farma S.P.A., Origgio, VA, Italy.

Sabrina Levi (S)

Novartis Argentina S.A., Ramallo, Argentina.

Ronald Zielman (R)

Novartis Pharma B.V., Amsterdam, Netherlands.

Elia Lahouiri (E)

LSC LifeSciences Consultants, Milan, Italy.

Marco Marchina (M)

LSC LifeSciences Consultants, Milan, Italy.

Marco Pedrazzoli (M)

LSC LifeSciences Consultants, Milan, Italy.

Matias Ferraris (M)

Novartis Pharma AG, Basel, Switzerland.

Classifications MeSH